WE SELL NOTHINGEVERY CLAIM → A PRIMARY SOURCEUNKNOWN IS A REAL ANSWERNO PRODUCTS · NO PROTOCOLS · NO VENDORSWE SELL NOTHINGEVERY CLAIM → A PRIMARY SOURCE
← All field guides
Field Guide 03 · reviewed July 17, 2026

Why the same ingredient name is not the same product

The fastest way to spot the product-identity leap behind peptide marketing.

TL;DR

An ingredient name does not prove chemical form, concentration, sterility, formulation, manufacturer, route, stability, labeling, or equivalence to the drug used in a clinical trial.

The label-name shortcut

A seller can print the name of a familiar peptide on a vial. That word does not show that the vial contains the same form, strength, purity, or formulation as an FDA-approved drug or research material.

Evidence follows the studied product

A clinical result belongs to the intervention the trial actually used. To transfer the result, you would need evidence that the other product is meaningfully equivalent for the question being asked. A shared ingredient name alone is not that evidence.

Sterility and strength are separate claims

Even correct chemical identity would not by itself establish sterile manufacturing, accurate concentration, stability, or freedom from harmful impurities. Those are product-quality questions, not conclusions supplied by a PubMed citation.

The six-line identity check

Ask: exact substance and chemical form; finished formulation; route; manufacturer; approved or trial product; and evidence connecting this exact product to the claimed outcome. If those answers are missing, the honest verdict is “product identity not established.”

Receipts

FDA — Understanding the Risks of Compounded DrugsOpen source ↗FDA — Unapproved DrugsOpen source ↗FDA warning letter concerning online peptide productsOpen source ↗
Boundary: This guide explains how PepCurrent reads public evidence. It is not a personal risk assessment, treatment recommendation, dosing guide, or legal opinion.